Monthly
US$200
Billed every month
Potassium Chloride Granules(氯化钾颗粒)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 2 applicationsAccepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders38View records ↓
Under-review filings4View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers50View records ↓
API companies with A status13View records ↓
Chemical-drug catalogue
Loaded records: 38 holders; 3 in the quality-and-efficacy consistency-evaluation category, and 34 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 西藏奥斯必秀医药有限公司 | 华益泰康药业股份有限公司 | 国药准字H20264543 | 2026/05/27 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西藏奥斯必秀医药有限公司 | 华益泰康药业股份有限公司 | 国药准字H20264542 | 2026/05/27 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20264259 | 2026/05/07 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20264258 | 2026/05/07 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 涿州东乐制药有限公司 | 涿州东乐制药有限公司 | 国药准字H20263837 | 2026/04/07 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 涿州东乐制药有限公司 | 涿州东乐制药有限公司 | 国药准字H20263836 | 2026/04/07 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北唯森制药有限公司 | 湖北唯森制药有限公司 | 国药准字H20263088 | 2026/01/14 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江赛默制药有限公司 | 浙江赛默制药有限公司 | 国药准字H20256201 | 2025/12/09 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东普瑞曼药业有限公司 | 山东普瑞曼药业有限公司 | 国药准字H20256165 | 2025/12/03 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川天杏汇医药科技有限公司 | 成都天台山制药股份有限公司 | 国药准字H20255992 | 2025/11/18 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 苏州朗科生物技术股份有限公司 | 南京海纳制药有限公司 | 国药准字H20255728 | 2025/10/21 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都通德药业有限公司 | 成都通德药业有限公司 | 国药准字H20255731 | 2025/10/21 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州森荣医药科技有限公司 | 金鸿药业股份有限公司 | 国药准字H20255536 | 2025/09/16 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州森荣医药科技有限公司 | 金鸿药业股份有限公司 | 国药准字H20255537 | 2025/09/16 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄康力药业有限公司 | 石家庄康力药业有限公司 | 国药准字H20255001 | 2025/07/29 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄康力药业有限公司 | 石家庄康力药业有限公司 | 国药准字H20255000 | 2025/07/29 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山西皇城相府药业股份有限公司 | 山西皇城相府药业股份有限公司 | 国药准字H20254802 | 2025/07/08 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山西皇城相府药业股份有限公司 | 山西皇城相府药业股份有限公司 | 国药准字H20254801 | 2025/07/08 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽佳和药业有限公司 | 安徽佳和药业有限公司 | 国药准字H20254770 | 2025/06/30 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北华晨药业集团有限公司 | 河北华晨药业集团有限公司 | 国药准字H20254610 | 2025/06/24 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北华晨药业集团有限公司 | 河北华晨药业集团有限公司 | 国药准字H20254609 | 2025/06/24 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北三禾实创生物科技有限公司 | 天津汉瑞药业有限公司 | 国药准字H20254500 | 2025/06/10 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北三禾实创生物科技有限公司 | 天津汉瑞药业有限公司 | 国药准字H20254499 | 2025/06/10 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 赤峰固得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20254413 | 2025/06/03 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆鑫禾生物科技有限责任公司 | 重庆科瑞南海制药有限责任公司 | 国药准字H20254412 | 2025/06/03 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20254319 | 2025/05/27 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福州基石医药科技有限公司 | 福州基石医药科技有限公司 | 国药准字H20254185 | 2025/05/13 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 福州基石医药科技有限公司 | 福州基石医药科技有限公司 | 国药准字H20254186 | 2025/05/13 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 贵州瑞和制药有限公司 | 天津汉瑞药业有限公司 | 国药准字H20253850 | 2025/04/08 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 贵州瑞和制药有限公司 | 天津汉瑞药业有限公司 | 国药准字H20253851 | 2025/04/08 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 济川药业集团有限公司 | 济川药业集团有限公司 | 国药准字H20253821 | 2025/04/08 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 济川药业集团有限公司 | 济川药业集团有限公司 | 国药准字H20253820 | 2025/04/08 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山西普德药业有限公司 | 山西普德药业有限公司 | 国药准字H20249672 | 2024/12/01 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南烨徽源医药科技有限公司 | 康芝药业股份有限公司 | 国药准字H20247296 | 2024/11/28 | 每袋1.05g：含氯化钾1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 国药集团国瑞药业有限公司 | 国药集团国瑞药业有限公司 | 国药准字H20249381 | 2024/11/15 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药谷制药有限公司 | 济川药业集团有限公司 | 国药准字H20244641 | 2024/08/05 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药谷制药有限公司 | 济川药业集团有限公司 | 国药准字H20244642 | 2024/08/05 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江高跖医药科技股份有限公司 | 海南皇隆制药股份有限公司 | 国药准字H20244649 | 2024/08/05 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江高跖医药科技股份有限公司 | 海南皇隆制药股份有限公司 | 国药准字H20244648 | 2024/08/05 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南烨徽源医药科技有限公司 | 康芝药业股份有限公司 | 国药准字H33020123 | 2024/08/01 | 每袋1.58g：含氯化钾1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京诚济制药股份有限公司 | 北京诚济制药股份有限公司 | 国药准字H20244501 | 2024/07/30 | 每袋含氯化钾1.0g | Not stated by source | CDE |
| 北京诚济制药股份有限公司 | 北京诚济制药股份有限公司 | 国药准字H20244502 | 2024/07/30 | 每袋含氯化钾1.5g | Not stated by source | CDE |
| 浙江同伍生物医药有限公司 | 四川科伦药业股份有限公司 | 国药准字H20244463 | 2024/07/16 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东九明制药有限公司 | 广东九明制药有限公司 | 国药准字H20244464 | 2024/07/16 | 每袋含氯化钾1.5g。 | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20244070 | 2024/06/18 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20244069 | 2024/06/18 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 武汉太福制药有限公司 | 武汉太福制药有限公司 | 国药准字H20247090 | 2024/04/30 | 每袋含氯化钾1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 武汉太福制药有限公司 | 武汉太福制药有限公司 | 国药准字H42022296 | 2024/04/30 | 每袋含氯化钾1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京柏雅联合药物研究所有限公司 | 湖南九典制药股份有限公司 | 国药准字H20243491 | 2024/04/11 | 1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东阳祥昇医药科技有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20243235 | 2024/02/23 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东阳祥昇医药科技有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20243234 | 2024/02/23 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州和泽坤元药业有限公司 | 四川科伦药业股份有限公司 | 国药准字H20243143 | 2024/02/06 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华诺医药（广州）有限公司 | 天津汉瑞药业有限公司 | 国药准字H20223630 | 2022/08/30 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华诺医药（广州）有限公司 | 天津汉瑞药业有限公司 | 国药准字H20223629 | 2022/08/30 | 每袋含氯化钾1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 重庆药友制药有限责任公司 | 国药准字H50020684 | 2018/11/19 | 1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 重庆药友制药有限责任公司 | 国药准字H50020683 | 2018/11/19 | 1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京海鲸药业股份有限公司 | 南京海鲸药业股份有限公司 | 国药准字H20254945 | 2025/07/22 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京海纳制药有限公司 | 南京海纳制药有限公司 | 国药准字H20254314 | 2025/05/27 | 每袋含氯化钾1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 50 distinct approval numbers and 33 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010100299 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020684 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010101066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244642 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010101453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010101966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010102068 | NHSA |
| 河北华晨药业集团有限公司 | 国药准字H20254610 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010102617 | NHSA |
| 石家庄康力药业有限公司 | 国药准字H20255000 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010102741 | NHSA |
| 石家庄四药有限公司 | 国药准字H20254319 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010102763 | NHSA |
| 山西皇城相府药业股份有限公司 | 国药准字H20254801 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010102892 | NHSA |
| 山西普德药业有限公司 | 国药准字H20249672 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010102918 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H20249381 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010104383 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001010104506 | NHSA |
| 湖北唯森制药有限公司 | 国药准字H20263088 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010106673 | NHSA |
| 贵州瑞和制药有限公司 | 国药准字H20253851 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010110247 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223629 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010110307 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20254314 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010180537 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244501 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010182209 | NHSA |
| 海南海和制药有限公司 | 国药准字H20243491 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010183184 | NHSA |
| 河北三禾实创生物科技有限公司 | 国药准字H20254500 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010183409 | NHSA |
| 杭州和泽坤元药业有限公司 | 国药准字H20243143 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010184206 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244069 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254666 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244648 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184221 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H20247296 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184245 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243235 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010184294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254186 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184338 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20256165 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010184621 | NHSA |
| 浙江同伍生物医药有限公司 | 国药准字H20244463 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010184712 | NHSA |
| 西藏奥斯必秀医药有限公司 | 国药准字H20264542 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184724 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254413 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010184867 | NHSA |
| 四川天杏汇医药科技有限公司 | 国药准字H20255992 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010185049 | NHSA |
| 安徽佳和药业有限公司 | 国药准字H20254770 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010185179 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010200299 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020684 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010201066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244642 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010201453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010201966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010202068 | NHSA |
| 河北华晨药业集团有限公司 | 国药准字H20254610 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010202617 | NHSA |
| 山西普德药业有限公司 | 国药准字H20249672 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010202918 | NHSA |
| 贵州瑞和制药有限公司 | 国药准字H20253851 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010210247 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223630 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010210307 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244501 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010282209 | NHSA |
| 海南海和制药有限公司 | 国药准字H20243491 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010283184 | NHSA |
| 杭州和泽坤元药业有限公司 | 国药准字H20243143 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010284206 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244069 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254666 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244648 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284221 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H20247296 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284245 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243235 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010284294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254186 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284338 | NHSA |
| 浙江同伍生物医药有限公司 | 国药准字H20244463 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010284712 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254413 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010284867 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010300299 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020684 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010301066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244642 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010301453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010301966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010302068 | NHSA |
| 山西普德药业有限公司 | 国药准字H20249672 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010302918 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223629 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010310307 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244501 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010382209 | NHSA |
| 海南海和制药有限公司 | 国药准字H20243491 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010383184 | NHSA |
| 杭州和泽坤元药业有限公司 | 国药准字H20243143 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010384206 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244069 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254666 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244648 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384221 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H20247296 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384245 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243235 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010384294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254186 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384338 | NHSA |
| 浙江同伍生物医药有限公司 | 国药准字H20244463 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010384712 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254413 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010384867 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010400299 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H50020684 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010401066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244642 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010401453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010401966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010402068 | NHSA |
| 山西普德药业有限公司 | 国药准字H20249672 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010402918 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223630 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010410307 | NHSA |
| 海南海和制药有限公司 | 国药准字H20243491 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010483184 | NHSA |
| 杭州和泽坤元药业有限公司 | 国药准字H20243143 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010484206 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244069 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010484209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254666 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010484220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244648 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010484221 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H20247296 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010484245 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243235 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010484294 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254413 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010484867 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010500299 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244642 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010501453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010501966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010502068 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223629 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010510307 | NHSA |
| 海南海和制药有限公司 | 国药准字H20243491 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010583184 | NHSA |
| 杭州和泽坤元药业有限公司 | 国药准字H20243143 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010584206 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H20247296 | 每袋1.05g:含氯化钾1.0g | Category A (甲) | XA12BAL208N001010584245 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243235 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010584294 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254413 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010584867 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010600299 | NHSA |
| 重庆安诺生生命科技有限公司 | 国药准字H20253820 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010601453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010601966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010602068 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223630 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010610307 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010700299 | NHSA |
| 重庆安诺生生命科技有限公司 | 国药准字H20253820 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010701453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010701966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010702068 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223629 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010710307 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010800299 | NHSA |
| 武汉太福制药有限公司 | 国药准字H42022296 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010801966 | NHSA |
| 成都通德药业有限公司 | 国药准字H20255731 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010802068 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223630 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010810307 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001010900299 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223629 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001010910307 | NHSA |
| 广东九明制药有限公司 | 国药准字H20244464 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001011000299 | NHSA |
| 华诺医药(广州)有限公司 | 国药准字H20223630 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001011010307 | NHSA |
| 重庆恒鑫生物技术开发有限责任公司 | 国药准字H50020683 | 每袋1.57g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020101066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244641 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020101453 | NHSA |
| 河北华晨药业集团有限公司 | 国药准字H20254609 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020102617 | NHSA |
| 石家庄康力药业有限公司 | 国药准字H20255001 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001020102741 | NHSA |
| 山西皇城相府药业股份有限公司 | 国药准字H20254802 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020102892 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020104506 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244502 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020182209 | NHSA |
| 河北三禾实创生物科技有限公司 | 国药准字H20254499 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020183409 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244070 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254667 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244649 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184221 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243234 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001020184294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254185 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184338 | NHSA |
| 西藏奥斯必秀医药有限公司 | 国药准字H20264543 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184724 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254414 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020184867 | NHSA |
| 重庆恒鑫生物技术开发有限责任公司 | 国药准字H50020683 | 每袋1.57g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020201066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244641 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020201453 | NHSA |
| 河北华晨药业集团有限公司 | 国药准字H20254609 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020202617 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020204506 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244502 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020282209 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244070 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020284209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254667 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020284220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244649 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020284221 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243234 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001020284294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254185 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020284338 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254414 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020284867 | NHSA |
| 重庆恒鑫生物技术开发有限责任公司 | 国药准字H50020683 | 每袋1.57g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020301066 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244641 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020301453 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020304506 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20244502 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020382209 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244070 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020384209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254667 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020384220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244649 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020384221 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243234 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001020384294 | NHSA |
| 恒衍生物医药技术(厦门)有限公司 | 国药准字H20254185 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020384338 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254414 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020384867 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244641 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020401453 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020404506 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20244070 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020484209 | NHSA |
| 浙江北生药业汉生制药有限公司 | 国药准字H20254667 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020484220 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244649 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020484221 | NHSA |
| 东阳祥昇医药科技有限公司 | 国药准字H20243234 | 每袋含氯化钾1.0g | Category A (甲) | XA12BAL208N001020484294 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254414 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020484867 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244641 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020501453 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001020504506 | NHSA |
| 赤峰固得药业有限公司 | 国药准字H20254414 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020584867 | NHSA |
| 重庆安诺生生命科技有限公司 | 国药准字H20253821 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020601453 | NHSA |
| 重庆安诺生生命科技有限公司 | 国药准字H20253821 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020701453 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020801966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001020901966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021001966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021101966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021201966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021301966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021401966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021501966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021601966 | NHSA |
| 武汉太福制药有限公司 | 国药准字H20247090 | 每袋含氯化钾1.5g | Category A (甲) | XA12BAL208N001021701966 | NHSA |
| 海南烨徽源医药科技有限公司 | 国药准字H33020123 | 每袋1.58g:含氯化钾1.5g | Category A (甲) | XA12BAL208N001030104506 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 4 filings and 4 distinct first applicants.
Generic 4
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 重庆希尔安药业有限公司;重庆国泰康宁制药有限责任公司 | CYHS2602172 | Generic | 2026/09/01 | Not stated by source | CDE |
| 淄博万杰制药有限公司 | CYHS2600797 | Generic | 2026/04/08 | Not stated by source | CDE |
| 石家庄凯赛医药科技有限公司;华夏国药（菏泽）制药有限公司 | CYHS2600553 | Generic | 2026/02/27 | Not stated by source | CDE |
| 福建瑞泰来医药科技有限公司;安徽佳和药业有限公司 | CYHS2503852 | Generic | 2025/11/01 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 重庆希尔安药业有限公司;重庆国泰康宁制药有限责任公司 | CYHS2602172 | Generic | 2026/09/01 | Not stated by source | CDE |
| 淄博万杰制药有限公司 | CYHS2600797 | Generic | 2026/04/08 | Not stated by source | CDE |
| 石家庄凯赛医药科技有限公司;华夏国药（菏泽）制药有限公司 | CYHS2600553 | Generic | 2026/02/27 | Not stated by source | CDE |
API registrations
Non-component matches: 13 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 氯化钾 | 湖南浩森制药有限公司 | Y20260000475 | I | Exact ingredient | 2026/06/09 | CDE |
| 氯化钾 | 湖南新绿方药业有限公司 | Y20240001312 | I | Exact ingredient | 2025/02/07 | CDE |
| 氯化钾 | 河南普瑞制药有限公司 | Y20200001526 | A | Exact ingredient | 2026/01/01 | CDE |
| 氯化钾 | Chemtrade Solutions LLC | Y20210000064 | I | Exact ingredient | 2021/02/03 | CDE |
| 氯化钾 | K+S Minerals and Agriculture GmbH | Y20200001313 | A | Exact ingredient | 2023/02/22 | CDE |
| 氯化钾 | 天津海光科技发展股份有限公司 | Y20190009650 | A | Exact ingredient | 2025/05/14 | CDE |
| 氯化钾 | 江苏省勤奋药业有限公司 | Y20190009523 | A | Exact ingredient | 2025/05/24 | CDE |
| 氯化钾 | 自贡鸿鹤制药有限责任公司 | Y20190009377 | A | Exact ingredient | 2025/03/29 | CDE |
| 氯化钾 | 河北华晨药业集团有限公司 | Y20190008767 | A | Exact ingredient | 2025/08/16 | CDE |
| 氯化钾 | 台山市新宁制药有限公司 | Y20190008432 | A | Exact ingredient | 2026/04/03 | CDE |
| 氯化钾 | 西安利君精华药业有限责任公司 | Y20190005465 | A | Exact ingredient | 2025/11/21 | CDE |
| 氯化钾 | 云南大唐汉方制药有限公司 | Y20190005363 | A | Exact ingredient | — | CDE |
| 氯化钾 | 吉林省西点药业科技发展股份有限公司 | Y20190003452 | A | Exact ingredient | 2025/09/18 | CDE |
| 氯化钾 | 北京市燕京药业有限公司 | Y20190002514 | A | Exact ingredient | 2026/02/04 | CDE |
| 氯化钾 | 重庆新大新药业股份有限公司 | Y20190001967 | A | Exact ingredient | 2026/05/20 | CDE |
| 氯化钾 | 自贡鸿鹤制药有限责任公司 | Y20180000646 | A | Exact ingredient | 2019/01/18 | CDE |
| 氯化钾 | Dead Sea Works Ltd. | Y20180001476 | A | Exact ingredient | 2026/04/21 | CDE |
| 氯化钾 | 天津海光药业股份有限公司 | Y20180000599 | I | Exact ingredient | 2018/12/17 | CDE |
| 氯化钾 | 江苏省勤奋药业有限公司 | Y20180000044 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/10/20Marketing application approved
南京黄龙生物科技有限公司
CYHS2500460 · 国药准字H20266302
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 25 ↗ -
2026/10/20Marketing application approved
南京黄龙生物科技有限公司
CYHS2500457 · 国药准字H20266301
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 24 ↗ -
2026/09/01Accepted
重庆希尔安药业有限公司;重庆国泰康宁制药有限责任公司
CYHS2602172
Fact date: 2026/09/01 · Site observation date: 2026/10/22
View source ↗ -
2026/08/18Accepted
吉林省西点药业科技发展股份有限公司;南京海纳制药有限公司
CYHB2601567
Fact date: 2026/08/18 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Potassium Chloride Granules
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy